Vialife SA
Vialife SA Fundamental Analysis
Vialife SA (ALVIA.PA) shows weak financial fundamentals with a PE ratio of 50.72, profit margin of 2.15%, and ROE of 14.33%. The company generates $0.0B in annual revenue with weak year-over-year growth of -2.03%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 31.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze ALVIA.PA's fundamental strength across five key dimensions:
Efficiency Score
WeakALVIA.PA struggles to generate sufficient returns from assets.
Valuation Score
ModerateALVIA.PA shows balanced valuation metrics.
Growth Score
WeakALVIA.PA faces weak or negative growth trends.
Financial Health Score
WeakALVIA.PA carries high financial risk with limited liquidity.
Profitability Score
WeakALVIA.PA struggles to sustain strong margins.
Key Financial Metrics
Is ALVIA.PA Expensive or Cheap?
P/E Ratio
ALVIA.PA trades at 50.72 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, ALVIA.PA's PEG of 0.51 indicates potential undervaluation.
Price to Book
The market values Vialife SA at 9.39 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 31.35 times EBITDA. This signals the market has high growth expectations.
How Well Does ALVIA.PA Make Money?
Net Profit Margin
For every $100 in sales, Vialife SA keeps $2.15 as profit after all expenses.
Operating Margin
Core operations generate 0.96 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $14.33 in profit for every $100 of shareholder equity.
ROA
Vialife SA generates $2.27 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Vialife SA generates strong operating cash flow of $1.26M, reflecting robust business health.
Free Cash Flow
Vialife SA generates strong free cash flow of $1.26M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $3.18 in free cash annually.
FCF Yield
ALVIA.PA converts 26.11% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
50.72
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.51
vs 25 benchmark
P/B Ratio
Price to book value ratio
9.39
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.09
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.15
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.84
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.14
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.04
vs 25 benchmark
How ALVIA.PA Stacks Against Its Sector Peers
| Metric | ALVIA.PA Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 50.72 | 24.16 | Worse (Expensive) |
| ROE | 14.33% | 1189.00% | Weak |
| Net Margin | 2.15% | 2648.00% | Weak |
| Debt/Equity | 1.15 | 0.70 | Weak (High Leverage) |
| Current Ratio | 0.84 | 2.85 | Weak Liquidity |
| ROA | 2.27% | -8318.00% (disorted) | Weak |
ALVIA.PA outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Vialife SA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-7.94%
Industry Style: Cyclical, Growth, Discretionary
DecliningEPS CAGR
-73.57%
Industry Style: Cyclical, Growth, Discretionary
DecliningFCF CAGR
0.00%
Industry Style: Cyclical, Growth, Discretionary
Declining